We Discuss Genomic Sequencing Efforts of Local COVID-19 Strains with Dr. Paraic Kenny of Kenny Lab

Below are the questions we asked Dr. Paraic Kenny about genomic sequencing and COVID-19

• First before we get into COVID-19 Dr. Kenney could you tell us about yourself. It certainly is impressive that you have your own lab. Kenny Lab, What got you interested in health and medicine not to mention research? 
• On to COVID-19 when did you first start thinking this virus was going to be a big problem? · What was the genesis of the study to better under stand COVID-19 strains?
• How did you get involved with the local health department (La Cross Public Health Department)? 
• We know that you have international partners in this endeavor? How did this come about? 
• What have you learned thus far about the novel coronavirus (SARS-CoV-2)? 
• Dr. Kenney we have heard that there are a number of SARS-CoV-2 strains—can you update the TrialSite Network audience—how many strains of SARS-CoV-2 are there? Are some more potent or dangerous than others? 
• Do all the strains originate from Wuhan China? Is that conclusive? 
• Based on your tests and investigation has any material strategies changed there at Gunderson in relation to COVID-19 treatments? 
• How far along is this type of testing and analysis coming along across the United States? 
• What are the implications for what you have accomplished thus far? 
• Gunderson Health System has a great reputation—could you name three things that make it stand apart for other researchers to hear? 
• Any parting words of wisdom for other researchers interested in similar pursuits? Any collaborations for them to consider